EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor

CHEBI:CHEBI_68640

Definition

An EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of cytochrome P450 17-alpha-hydroxylase/C17,20-lyase (EC 1.14.99.9).

Alternative Names

  • 17-alpha-hydroxylase/C17,20-lyase inhibitor
  • 17-alpha-hydroxylase/C17,20-lyase inhibitors
  • 17alpha-hydroxylase-C17,20 lyase inhibitor
  • 17alpha-hydroxylase-C17,20 lyase inhibitors
  • CYP17 inhibitor
  • CYP17 inhibitors
  • CYP17A1 inhibitor
  • CYP17A1 inhibitors
  • cytochrome P-45017alpha inhibitor
  • cytochrome P-45017alpha inhibitors
  • cytochrome P450 (P-45017alpha,lyase) inhibitor
  • cytochrome P450 (P-45017alpha,lyase) inhibitors
  • cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitor
  • cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitors
  • cytochrome p450 XVIIA1 inhibitor
  • cytochrome p450 XVIIA1 inhibitors
  • EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitors
  • EC 1.14.99.9 inhibitor
  • EC 1.14.99.9 inhibitors
  • steroid 17alpha-hydroxylase inhibitor
  • steroid 17alpha-hydroxylase inhibitors
  • steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitor
  • steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitors
  • steroid 17alpha-monooxygenase inhibitor
  • steroid 17alpha-monooxygenase inhibitors
  • steroid 17alphahydroxylase/17,20 lyase inhibitor
  • steroid 17alphahydroxylase/17,20 lyase inhibitors
  • steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitor
  • steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitors

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:68640
oboInOwl#hasDbXref
Wikipedia:CYP17A1

Additional References

Wikipedia:CYP17A1

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:68640
core#notation
CHEBI:68640
oboInOwl#hasDbXref
Wikipedia:CYP17A1
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_68642
owl#annotatedSource
t276800
owl#someValuesFrom
t276693